Literature DB >> 32601969

Magnetic resonance imaging and bioimpedance evaluation of lymphatic abnormalities in patients with breast cancer treatment-related lymphedema.

Paula M C Donahue1,2, Rachelle Crescenzi3, Chelsea Lee4, Maria Garza3, Niral J Patel4, Kalen J Petersen3, Manus J Donahue5,6,7.   

Abstract

PURPOSE: Breast cancer treatment-related lymphedema (BCRL) evaluation is frequently performed using portable measures of limb volume and bioimpedance asymmetry. Here quantitative magnetic resonance imaging (MRI) is applied to evaluate deep and superficial tissue impairment, in both surgical and contralateral quadrants, to test the hypothesis that BCRL impairment is frequently bilateral and extends beyond regions commonly evaluated with portable external devices.
METHODS: 3-T MRI was applied to investigate BCRL topographical impairment. Female BCRL (n = 33; age = 54.1 ± 11.2 years; stage = 1.5 ± 0.8) and healthy (n = 33; age = 49.4 ± 11.0 years) participants underwent quantitative upper limb MRI relaxometry (T2), bioimpedance asymmetry, arm volume asymmetry, and physical evaluation. Parametric tests were applied to evaluate study measurements (i) between BCRL and healthy participants, (ii) between surgical and contralateral limbs, and (iii) in relation to clinical indicators of disease severity. Two-sided p-value < 0.05 was required for significance.
RESULTS: Bioimpedance asymmetry was significantly correlated with MRI-measured water relaxation (T2) in superficial tissue. Deep muscle (T2 = 37.6 ± 3.5 ms) and superficial tissue (T2 = 49.8 ± 13.2 ms) relaxation times were symmetric in healthy participants. In the surgical limbs of BCRL participants, deep muscle (T2 = 40.5 ± 4.9 ms) and superficial tissue (T2 = 56.0 ± 14.8 ms) relaxation times were elevated compared to healthy participants, consistent with an edematous micro-environment. This elevation was also observed in contralateral limbs of BCRL participants (deep muscle T2 = 40.3 ± 5.7 ms; superficial T2 = 56.6 ± 13.8 ms).
CONCLUSIONS: Regional MRI measures substantiate a growing literature speculating that superficial and deep tissue, in surgical and contralateral quadrants, is affected in BCRL. The implications of these findings in the context of titrating treatment regimens and understanding malignancy recurrence are discussed.

Entities:  

Keywords:  Bioimpedance spectroscopy; Breast cancer; Lymphatic; Lymphedema; MRI; Radiology

Mesh:

Year:  2020        PMID: 32601969      PMCID: PMC8086787          DOI: 10.1007/s10549-020-05765-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  54 in total

Review 1.  Health-related quality of life with lymphoedema: a review of the literature.

Authors:  Philip A Morgan; Peter J Franks; Christine J Moffatt
Journal:  Int Wound J       Date:  2005-03       Impact factor: 3.315

Review 2.  Imaging the lymphatic system.

Authors:  Lance L Munn; Timothy P Padera
Journal:  Microvasc Res       Date:  2014-06-21       Impact factor: 3.514

Review 3.  Manual lymphatic drainage for lymphedema following breast cancer treatment.

Authors:  Jeanette Ezzo; Eric Manheimer; Margaret L McNeely; Doris M Howell; Robert Weiss; Karin I Johansson; Ting Bao; Linda Bily; Catherine M Tuppo; Anne F Williams; Didem Karadibak
Journal:  Cochrane Database Syst Rev       Date:  2015-05-21

4.  Preoperative planning of lymphaticovenous anastomosis: The use of magnetic resonance lymphangiography as a complement to indocyanine green lymphography.

Authors:  G Pons; J A Clavero; X Alomar; E Rodríguez-Bauza; L K Tom; J Masia
Journal:  J Plast Reconstr Aesthet Surg       Date:  2019-03-02       Impact factor: 2.740

5.  L-dex ratio in detecting breast cancer-related lymphedema: reliability, sensitivity, and specificity.

Authors:  M R Fu; C M Cleland; A A Guth; M Kayal; J Haber; F Cartwright; R Kleinman; Y Kang; J Scagliola; D Axelrod
Journal:  Lymphology       Date:  2013-06       Impact factor: 1.286

6.  Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy.

Authors:  Pat W Whitworth; Andrea Cooper
Journal:  Breast J       Date:  2017-10-24       Impact factor: 2.431

7.  How is lymphofluoroscopy mapping altering lymphoedema management?

Authors:  Jane Wigg; Garry Cooper
Journal:  Br J Community Nurs       Date:  2017-10-01

8.  Lymphatic dysfunction in the apparently clinically normal contralateral limbs of patients with unilateral lower limb swelling.

Authors:  Katherine M Burnand; Daphne M Glass; Peter S Mortimer; Adrien Michael Peters
Journal:  Clin Nucl Med       Date:  2012-01       Impact factor: 7.794

Review 9.  Regulation of tumor invasion by interstitial fluid flow.

Authors:  Adrian C Shieh; Melody A Swartz
Journal:  Phys Biol       Date:  2011-02-07       Impact factor: 2.583

10.  Breast cancer survivors with lymphedema: glimpses of their daily lives.

Authors:  Sheila H Ridner; Vaughn Sinclair; Jie Deng; Candace M Bonner; Nancy Kidd; Mary S Dietrich
Journal:  Clin J Oncol Nurs       Date:  2012-12       Impact factor: 1.027

View more
  1 in total

1.  Elevated magnetic resonance imaging measures of adipose tissue deposition in women with breast cancer treatment-related lymphedema.

Authors:  Rachelle Crescenzi; Paula M C Donahue; Maria Garza; Chelsea A Lee; Niral J Patel; Victoria Gonzalez; R Sky Jones; Manus J Donahue
Journal:  Breast Cancer Res Treat       Date:  2021-10-23       Impact factor: 4.624

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.